Zafirlukast in Treatment of Marker Relapsed Ovarian Cancer
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This research study is evaluating the effectiveness of Zafirlukast to prevent tumor activity
in participants with tumor marker-only relapsed ovarian cancer.
- The name of the study drug involved in this study is:
- Zafirlukast